investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Gene therapy of chemoresistant and metastatic cancers (CANADA RESEARCH CHAIRHOLDER)

Eric Asselin

0 Collaborator(s)

Funding source

Canadian Institutes of Health Research (CIHR)
Dr. Asselin seeks to understand the cellular and molecular signalling mechanisms that control the fate of cells in the endometrium (ie survival vs. cell death). Backed by a team of 13 people, his group will study normal physiology (pregnancy, embryo implantation) and pathologies of the reproductive tract (gyneacological endometrial and ovarian cancers). Very few studies concerning the regulation of apoptosis in the uterus have been published to date. Dr. Asselin and his team also developed patented molecules for targeting specific hormone-dependent cancers. The proposed program will elucidate new pathways and will propose innovative strategies for gene therapy of chemoresistant and metastatic cancers and treatment of female infertility.

Related projects